Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 4, 1999, Pages 954-956

  Bebear, Cécile M ^a,b   Renaudin, Joel ^b   Charron, Alain ^a   Renaudin, Hélène ^a   De Barbeyrac, Bertille ^a   Schaeverbeke, Thierry ^a   Bebear, Christiane ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; JOSAMYCIN; NOVOBIOCIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA HOMINIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0032918134     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.4.954     Document Type: Article

References (21)

1. Bébéar, C. M., J. M. Bové, C. Bébéar, and J. Renaudin. 1997. Characterization of Mycoplasma hominis mutations involved in resistance to fluoroquinolones. Antimicrob. Agents Chemother. 41:269-273.
2. Bébéar, C. M., A. Charron, J. M. Bové, C. Bébéar, and J. Renaudin. 1998. Cloning and nucleotide sequence of the topoisomerase IV parC and parE genes of Mycoplasma hominis. Antimicrob. Agents Chemother. 42:2024-2031.
3. Bébéar, C. M., H. Renaudin, A. Charron, J. M. Bové, C. Bébéar, and J. Renaudin. 1998. Alterations in topoisomerase IV and DNA gyrase in quinolone-resistant mutants of Mycoplasma hominis obtained in vitro. Antimicrob. Agents Chemother. 42:2304-2311.
4. Breines, D. M., S. Ouabdesselam, E. Y. Ng, J. Tankovic, S. Shah, C. J. Soussy, and D. C. Hooper. 1997. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob. Agents Chemother. 41:175-179.
5. Contreras, A., and A. Maxwell. 1992. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase. Mol. Microbiol. 6:1617-1624.
6. Cummings, M., and W. McCormack. 1990. Increase in resistance of Mycoplasma hominis to tetracyclines. Antimicrob. Agents Chemother. 34:2297-2299.
7. Deguchi, D., M. Yasuda, N. Nakano, E. Kanematsu, S. Oseki, Y. Nishino, T. Esaki, S.-I. Maeda, I. Saito, and Y. Kawada. 1997. Rapid screening of point mutations of the Neisseria gonorrhoeae parC gene associated with resistance to quinolones. J. Clin. Microbiol. 35:948-950.
8. Fournier, B., and D. C. Hooper. 1998. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity. Antimicrob. Agents Chemother. 42:121-128.
9. Gellert, M., K. Mizuuchi, M. H. O'Dea, and H. A. Nash. 1976. DNA gyrase: an enzyme that introduces superhelical turns into DNA. Proc. Natl. Acad. Sci. USA 73:3872-3876.
10. Ito, H., H. Yoshida, M. Bogaki-Shonai, T. Niga, H. Hattori, and S. Nakamura. 1994. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob. Agents Chemother. 38: 2014-2023.
11. Khodursky, A. B., E. L. Zechiedrich, and N. R. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. 92:11801-11805.
12. Ladefoged, S. A., and G. Christiansen. 1994. Sequencing analysis reveals a unique gene organization in the gyrB region of Mycoplasma hominis. J. Bacteriol. 176:5835-5842.
13. Muñoz, R., M. Bustamante, and A. de la Campa. 1995. Ser-127-to-Leu substitution in the DNA gyrase B subunit of Streptococcus pneumoniae is implicated in novobiocin resistance. J. Bacteriol. 177:4166-4170.
14. Pan, X.-S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
15. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux system. Microbiol. Rev. 60:575-608.
16. Périchon, B., J. Tankovic, and P. Courvalin. 1997. Characterization of a mutation in the parE gene that confers fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:1166-1167.
17. Pestova, E. V., R. Beyer, C. A. Noskin, and L. R. Peterson. 1998. Characterization of mutations in DNA gyrase and topoisomerase IV from clinical isolates of Streptococcus pneumoniae with variable resistance to fluoroquinolones and antimicrobial agents, abstr. V133, p 535. In Program and abstracts of the 98th General Meeting of the American Society for Microbiology 1998. American Society for Microbiology. Washington, D.C.
18. Ruiz, J., S. Casellas, M. T. Jimenez de Anta, and J. Vila. 1997. The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates. J. Antimicrob. Chemother. 39:839-840.
19. Schmitz, F.-S., M. E. Jones, B. Hofmann, B. Hansen, S. Scheuring, M. Lückefahr, A. Fluit, J. Verhoef, U. Hadding, H. P. Heinz, and K. Köhrer. 1998. Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC. Antimicrob. Agents Chemother. 42:1249-1252.
20. Tanaka, M., Y. Onodera, Y. Uchida, K. Sato, and Y. Hayakawa. 1997. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus. Antimicrob. Agents Chemother. 41: 2362-2366.
21. Yoshida, H., M. Bogaki, M. Nakamura, L. M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.